Document is current
Any future updates will be listed below
-
Authors
Yang, Wenjin
Soomro, Jazba
Jansen, Ivo G. H. https://orcid.org/0000-0002-8862-1877
Venkatesh, Aashish
Yoo, Albert J. https://orcid.org/0000-0002-7657-142X
Lopes, Demetrius https://orcid.org/0000-0002-6280-0113
Beenen, Ludo F. M. https://orcid.org/0000-0001-9204-1026
Emmer, Bart J. https://orcid.org/0000-0001-8462-4037
Majoie, Charles B. L. M. https://orcid.org/0000-0002-7600-9568
Marquering, Henk A. https://orcid.org/0000-0002-1414-6313
-
Funding
Funding for this research was provided by:
China Scholarship Council (201908310004)
- License Information
-
More Information
Article History
Received: 2 January 2022
Accepted: 30 August 2022
First Online: 26 September 2022
Declarations
:
: C.B.L.M. Majoie, H.A. Marquering and I.G.H. Jansen are shareholders of Nico-lab. A.J. Yoo holds stock options in Nico-lab and reports grants from Medtronic, Cerenovus, Penumbra, Stryker, and Genentech, and is a consultant for Vesalio, Cerenovus, Penumbra, and Philips, all outside the submitted work. C.B.L.M. Majoie reports grants from CVON/Dutch Heart Foundation, TWIN Foundation, European Commission, Health Evaluation Netherlands, and Stryker outside the submitted work (all paid to institution). W. Yang, J. Soomro, A. Venkatesh, D. Lopes, L.F.M. Beenen and B.J. Emmer declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review boards. Informed consent: informed consent was not required because of the anonymization of all data in this study.
